Discover 920 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 920
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: Portland OR, Santa Monica CA, Duarte CA, Denver CO,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase1, Recruiting
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Portland OR, Oregon City OR, Newberg OR, Seattle WA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05633615
Phase2, Recruiting
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Portland OR, Louisville KY, Toronto, Richmond VA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06282575
Phase3, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
for
Lymphatic Malformations
Location: Portland OR, Seattle WA, Oakland CA, Palo Alto CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT05948943
Phase2, Phase3, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Portland OR, Oregon City OR, Newberg OR, Salem OR,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
for
Pyoderma Gangrenosum
Location: Portland OR, Meridian ID, Murray UT, Edmonton,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT06624670
Phase3, Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Location: Portland OR, Seattle WA, Los Angeles CA, La Jolla CA,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 12+
Code: NCT04585750
Phase1, Phase2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Portland OR, Oregon City OR, Seattle WA, Vancouver,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase2, Phase3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
for
Advanced Hepatocellular Carcinoma,
Location: Portland OR, Orange CA, Irvine CA, Pittsburgh PA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06811116
Phase1, Phase2, Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation